Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
4.500
+1.500 (50.00%)
Apr 28, 2025, 1:51 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $33.79 million as of April 28, 2025. Its market cap has increased by 16,115.47% in one year.
Market Cap
33.79M
Enterprise Value
34.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.50
Market Cap Chart
Since February 14, 2022, Propanc Biopharma's market cap has increased from 1.26M to 33.79M, an increase of 2,587.13%. That is a compound annual growth rate of 180.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 34.84M | 20,907.93% |
| Dec 31, 2024 | 165.82K | -50.41% |
| Dec 29, 2023 | 334.41K | -33.52% |
| Dec 30, 2022 | 502.99K | -60.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Glass House Brands | 483.81M |
| Elite Pharmaceuticals | 443.14M |
| Northwest Biotherapeutics | 402.45M |
| CytoDyn | 288.39M |
| BioStem Technologies | 245.41M |